E D U C AT I O N

1996 M.D. University of California, Los Angeles, School of Medicine

1993 B.S. University of California, Riverside

P O S T D O C T O R A L T R A I N I N G

2000-2003 Fellow, Medical Oncology and Therapeutics Research City of Hope National Medical Center, Duarte, California

1997-1999 Resident, Internal Medicine Harbor-UCLA Medical Center, Torrance, California

C U R R E N T P R A C T I C E

2003 - Present Los Alamitos Hematology / Oncology Los Alamitos Medical Center, Los Alamitos, CA

2011 - Present Chief of Staff Los Alamitos Medical Center, Los Alamitos, CA

C E R T I F I C AT I O N

American Board of Hematology

American Board of Internal Medicine

American Board of Medical Oncology

A C A D E M I C A P P O I N T M E N T S

2003 - Present Clinical Associate Professor David Geffen / UCLA School of Medicine

Sandeep K. Reddy, MD Senior Medical Director

© 2013 Caris Life Sciences and affiliates. All rights reserved. TN0104 1.13

To order Caris Molecular Intelligence Services or to speak with a Caris Life Sciences’ representative, call

( 8 8 8 ) 9 7 9 - 8 6 6 9 or visit us online at www.CarisMolecularIntelligence.com.

“KRAS mutations (MTs) in non-small cell lung cancer (NSCLC) versus colorectal cancer (CRC): Implications for cetuximab therapy.” K. D. Danenberg, P. P. Grimminger, P. C. Mack, P. V. Danenberg, J. Cooc, C. Stephens, S. K. Reddy, T. Li, D. R. Gandara; Response Genetics, Los Angeles, CA; Department of General, Visceral, and Cancer Surgery, University of Cologne, Cologne, Germany; University of California, Davis, Sacramento, CA; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA; Harbor UCLA Medical Center, Los Alamitos, CA ASCO 2010 A51716

“ERCC, TS, RRM1, EGFR, and KRAS biomarker integration into a community-based medical oncology practice. “ Reddy S, et al. ASCO 2010 A#6156

“Pilot study of fixed-dose bevacizumab (200 mg) for solid malignancies.” Reddy, S. Curti, M. Janis, M. Minow, R. J Clin Oncol 27, 2009 (suppl; abstr e14600)

“ACE-011, a soluble activin receptor type Iia IgG-Fc fusion protein, increases hemoglobin and hematocrit levels in postmenopausal healthy women” Kim, K, Borgstein N, Yang Y, Haltom E, Mook L, Ababa M, Reddy, S. American Society of Hematology Annual Meeting Abstract #3866 Nov 2008; 112

“Non-small cell lung cancer in patients aged 75 years and older: A community-based experience” Reddy, S. Berdan M., et al. J Clin Oncol 26: 2008 (May 20 suppl; Abstract #20676)

Chapter: “Male Breast Cancer” by Sandeep Reddy and Lucille Leong in Pathophysiology of Male Sexual Dysfunction, Kandeel F., Swerdloff R. et al. Marcell Dekker, in press

“Case report of Temozolamide associated steroid-refractory ITP and successful treatment with Rituximab” Reddy, S. Janis M., et al. American Society of Hematology Annual Meeting Abstract #4015

“Phase I trial of tamoxifen (Tam), carboplatin (C), and topotecan (T) in recurrent or metastatic brain tumors” Robert Morgan Jr., Timothy Synold, Adam Mamelak, Kim Margolin, Al-Kadhimi Zaid, Przemyslaw Twardowski, Lucille Leong, Dean Lim, Sandeep Reddy, Isan Chen, Warren Chow, Stephen Shibata, George Somlo, Yun Yen, Paul Frankel, James H Doroshow. American Society of Clinical Oncology Annual Meeting Abstract #2102

Poster: “Liposomal Amphotericin B is more effective than Amphotericin B in a case of AML related Rhinocerebral Mucormycosis” Reddy, S. Beck, K. ACP Southern California Associates’ Poster Competition

S E L E C T P U B L I C AT I O N S

P R O F E S S I O N A L S O C I E T I E S

American Society of Clinical Oncology International Society of Geriatric Oncology

American Society of Hematology International Association for the Study of Lung Cancer